Aspartame: Neuropsychologic and neurophysiologic evaluation of acute and chronic effects

American Journal of Clinical Nutrition

Volumn 68, Issue 3, 1998, Pages 531-537

  Spiers, Paul A ^a   Sabounjian, LuAnn ^a   Reiner, Allison ^a   Myers, Diane K ^b   Wurtman, Judith ^a   Schomer, Donald L ^a  

^a E18 408 ^*

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Adverse experience; Artificial sweetener; Aspartame; Behavior; Cognition; Humans; Large neutral amino acids; Mood; Neurophysiology; Neuropsychology; Phenylalanine; Side effect; Sucrose

Indexed keywords

ASPARTAME; PHENYLALANINE; SWEETENING AGENT;

ACNE; ADULT; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MONITORING; ELECTROENCEPHALOGRAM; FATIGUE; FEMALE; HEADACHE; HUMAN; LABORATORY TEST; MALE; MOOD; NAUSEA; NEUROPHYSIOLOGY; NEUROPSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL;

EID: 0031667409     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/68.3.531     Document Type: Article

References (42)

1. Bradstock MK, Serdula MK, Marks SJ, et al. Evaluation of reactions to food additives: the aspartame experience. Am J Clin Nutr 1986;43:464-9.
2. Garriga MM, Berkebile C, Metcalfe DD. A combined single-blind, double-blind, placebo-controlled study to determine the reproducibility of hypersensitivity reactions to aspartame. J Allergy Clin Immunol 1991;87:821-7.
3. Ferguson JM. Interaction of aspartame and carbohydrates in an eating disordered patient. Am J Psychiatr 1985;142:2:271 (letter).
4. Drake ME. Panic attacks and excessive aspartame ingestion. Lancet 1986;2:631 (letter).
5. Walton RG. Seizure and mania after high intake of aspartame. Psychosomatics 1986;27:218-20.
6. Tollefson L, Barnard RJ. An analysis of FDA passive surveillance reports of seizures associated with consumption of aspartame. J Am Diet Assoc 1992;92:598-601.
7. During MJ, Ackworth IN, Wurtman RJ. An in vivo study of dopamine release in striatum: the effects of phenylalanine. In: Wurtman RJ, Ritter-Walker E, eds. Dietary phenylalanine and brain function. Boston: Birkhauser, 1988:81-6.
8. Fernstrom JD. Effects of aspartame ingestion on large neutral amino acids and monoamine neurotransmitters in the central nervous system. In: Wurtman RJ, Ritter-Walker E, eds. Dietary phenylalanine and brain function. Boston: Birkhauser, 1988:87-94.
9. Stegink LD. Aspartame metabolism in humans: acute dosing studies. In: Stegink LD, Filer LJ, eds. Aspartame: physiology and biochemistry. New York: Marcel Dekker, 1984:509-53.
10. Visek WJ. Chronic ingestion of aspartame in humans. In: Stegink LD, Filer LJ, eds. Aspartame: physiology and biochemistry. New York: Marcel Dekker, 1984:495-508.
11. Ferguson HB, Stoddart C, Simeone JG. Double-blind challenge studies of behavioral and cognitive effects of sucrose-aspartame ingestion in normal children. Nutr Rev 1986;44(suppl):144-50.
12. Kruesi MJP, Rapoport JL, Cummings EM, et al. Effects of sugar and aspartame on aggression and activity in children. Am J Psychiatr 1987;144:1487-90.
13. Saravis S, Schachar R, Zlotkin S, Leiter LA, Anderson GH. Aspartame: effects on learning, behavior and mood. Pediatrics 1990;86:75-83.
14. Ryan-Harshman M, Leiter LA, Anderson GH. Phenylalanine and aspartame fail to alter feeding behavior, mood and arousal in men. Physiol Behav 1987;39:247-53.
15. Stokes AF, Belger A, Banich MT, Bernardine E. Effects of alcohol and chronic aspartame ingestion upon performance in aviation relevant cognitive tasks. Aviat Space Environ Med 1994;65:7-15.
16. Lajtha A, Reilly MA, Dunlop DS. Aspartame consumption: lack of effects on neural function. J Nutr Biochem 1994;5:266-83.
17. Wurtman RJ. Aspartame: possible effect on seizure susceptibility. Lancet 1985;2:1060 (letter).
18. Spiers PA, Schomer DL, Sabounjian LA, et al. Aspartame and human behavior: cognitive and behavioral observations. In: Wurtman RJ, Ritter-Walker E, eds. Dietary phenylalanine and brain function. Boston: Birkhauser, 1988:169-78.
19. Steffin S, Harris D. ThinkFast. Calabasas, CA: Brainpower Corp, 1985.
20. Lezak M. Neuropsychological assessment. 2nd ed. New York: Oxford University Press, 1983.
21. McGlone J. Sex difference in human brain asymmetry: a critical review. Behav Brain Sci 1980;3:215-63.
22. Health Protection Branch. Information letter: aspartame. Ottawa, Canada: Health and Welfare Canada, 1987.
23. McNair DM, Lorr M, Droppelman LF. Profile of mood states (POMS). San Diego: Educational and Industrial Testing Service, 1981.
24. Denckla WD, Dewey HR. The determination of tryptophan in plasma, liver, and urine. J Lab Clin Med 1967;69:160-9.
25. Slein MW. In: Bergmeyer HU, ed. Methods of enzymatic analysis. New York: Academic Press, 1963.
26. Fleiss JL. Statistical methods for rates and proportions. New York: Wiley & Sons, 1981:113-5.
27. Filer LJ, Stegink LD. Effect of aspartame on plasma phenylalanine concentration in humans. In: Wurtman RJ, Ritter-Walker E, eds. Dietary phenylalanine and brain function. Boston: Birkhauser, 1988:18-40.
28. Butchko HH, Kotsonis FN. Acceptable daily intake vs actual intake: the aspartame example. J Am Coll Nutr 1991;10:3:258-66.
29. Heybach JP, Ross C. Aspartame consumption in a representative sample of Canadians. Rev Assoc Can Diet 1989;50:166-70.
30. Ministry of Agriculture and Fisheries. Food intakes of intense and bulk sweeteners in the UK 1987-1988. London: Her Majesty's Stationery Office, 1990. (Food Surveillance Paper no. 29.)
31. Bar A, Biermann CH. Intake of intense sweeteners in Germany. Z Ernahrungswiss 1992;31:25-39.
32. Wolraich ML, Lindgren SD, Stumbo PJ, Stegink LD, Appelbaum MI, Kiritsy MC. Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children. N Engl J Med 1994;330:301-7.
33. Camfield PR, Camfield C, Dooley JM, Gordon K, Jollymore S, Weaver D. Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: a double-blind controlled study. Neurology 1992;42:1000-3.
34. Shaywitz BA, Novotny EJ, Ebersole JS, Anderson GM, Sullivan CM, Gillespie SM. Aspartame does not provoke seizures in children with epilepsy. Pediatr Res 1992;31:354A (abstr).
35. Shaywitz BA, Anderson GM, Novotny EJ, Ebersole JS, Sullivan CM, Gillespie SM. Aspartame has no effect on seizures or epileptiform discharges in epileptic children. Ann Neurol 1994;35:98-103.
36. Shaywitz BA, Sullivan CM, Anderson GM, Gillespie SM, Sullivan B, Shaywitz SE. Aspartame, behavior, and cognitive function in children with attention deficit disorder. Pediatrics 1994;93:70-5.
37. Rowan AJ, Shaywitz BA, Tuchman L, French JA, Luciano D, Sullivan CM. Aspartame and seizure susceptibility: results of a clinical study in reportedly sensitive individuals. Epilepsia 1995;36:270-5.
38. Trefz F, de Sonneville L, Matthis P, Benninger C, Lanz-Englert B, Bickel H. Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine). Hum Genet 1994;93:369-74.
39. Hertelendy ZI, Mendenhall CL, Rouster SD, Marshall L, Weesner R. Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease. Am J Gastroenterol 1993;88:737-43.
40. Leon AS, Hunningshake DB, Bell C, Rassin DK, Tephly TR. Safety of long-term large doses of aspartame. Arch Intern Med 1989;149:2318-24.
41. Ballard JC, Beehler GP. Aspartame use, self-reported neurological symptoms, and cognitive performance. Poster presentation. Proceedings of the 8th Annual Meeting of the American Neuropsychiatrie Association. Int J Neuropsychiatr Clin Neurosci 1997;9:147 (abstr).
42. Frasca MA, Aldag JC. The single-patient clinical trial. Am Fam Physician 1988;Mar:195-9.